Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-2,970
Closed -$20K 124
2017
Q4
$20K Buy
2,970
+181
+6% +$1.16K 0.01% 302
2017
Q3
$19K Hold
2,789
0.01% 300
2017
Q2
$15K Buy
2,789
+390
+16% +$2.22K 0.01% 332
2017
Q1
$13K Buy
2,399
+889
+59% +$4.88K 0.01% 347
2016
Q4
$7K Buy
1,510
+380
+34% +$2.05K ﹤0.01% 390
2016
Q3
$7K Hold
1,130
﹤0.01% 366
2016
Q2
$7K Buy
1,130
+60
+6% +$322 ﹤0.01% 360
2016
Q1
$6K Buy
+1,070
New +$4.92K ﹤0.01% 364

Other funds holding ABEV

Winfield Associates's ABEV Position: Q1 2018 in Review

Winfield Associates sold out of Ambev (ABEV) in Q1 2018, closing a stake of 2,970 shares — an estimated $20K sold.

Winfield Associates first reported a position in ABEV in Q1 2016 and held it in 8 quarters. The position peaked at $20K in Q4 2017. 334 funds tracked by Wall St. Rank hold ABEV as of Q1 2018.

  • Winfield Associates reported no remaining Ambev position as of Q1 2018 after selling out during the quarter.
  • Winfield Associates sold 2,970 Ambev shares in Q1 2018, an estimated $20K.
  • Winfield Associates first reported a position in Ambev in Q1 2016 and held it in 8 quarters.
  • Winfield Associates's Ambev position peaked at $20K in Q4 2017.
  • 334 funds tracked by Wall St. Rank held Ambev as of Q1 2018.

Based on Winfield Associates's 13F filing for Q1 2018, filed 10 May 2018.